GlassScriptPhysician profile
Sarah Levitt
NPI 1730940693
$2,340.49
in general payments reported to CMS, 2019-2025
18 companies · $1,812 in 2025
The $1,812 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $528 · 2025: $1,812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,340.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $611.03 | 2025 | Rezdiffra |
| Lilly USA, LLC | $311.39 | 2024-2025 | Omvoh |
| Abbvie INC. | $272.22 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $237.46 | 2024-2025 | Xifaxan |
| Janssen Biotech, INC. | $232.65 | 2024-2025 | Tremfya, Stelara, Simponi Aria |
| Qol Medical, LLC | $155.30 | 2024-2025 | Sucraid, Sucraid |
| Janssen Scientific Affairs, LLC | $94.79 | 2025 | Tremfya |
| Ardelyx, INC. | $69.93 | 2024-2025 | Ibsrela |
| Novo Nordisk INC | $66.21 | 2025 | Wegovy |
| Gilead Sciences, INC. | $54.52 | 2024-2025 | |
| Redhill Biopharma INC. | $49.52 | 2024-2025 | Talicia |
| Celltrion USA INC. | $45.67 | 2024-2025 | Vegzelma |
| Ipsen Biopharmaceuticals, INC | $34.43 | 2025 | Iqirvo |
| Braintree Laboratories, INC. | $31.18 | 2025 | Sutab, Suflave |
| Regeneron Healthcare Solutions, INC. | $21.15 | 2025 | Dupixent |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $20.40 | 2025 | |
| Pfizer INC. | $16.64 | 2025 | |
| Genzyme Corporation | $16.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Levitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.